Vagmine Pharmaceuticals Private Limited

Vagmine Pharmaceuticals Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN U33209PN2020PTC189998 Incorporated 20 February 2020 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹3.13 Lakh
▼ 37% YoY
Net profit · FY 2025
₹5,704
Net margin 1.8%
EBITDA · FY 2025
₹7,708
EBITDA margin 2.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Vagmine Pharmaceuticals Private Limited

Data last updated:

Vagmine Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 February 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U33209PN2020PTC189998.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amarjit Arun Dhalpe and Shruti Amarjit Dhalpe.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pno 92 Rajland Colony Tal Maval Dist Pune Talegaon, Maharashtra, India – 410507.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.13 Lakh, a decline of 37% compared to the previous year. For the same year it recorded a net profit of ₹5,704 (net margin 1.8%) and EBITDA of ₹7,708 (EBITDA margin 2.5%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years.

Vagmine Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0380284).

Company details

CIN U33209PN2020PTC189998
Registration Number 189998
Incorporation Date 20 February 2020
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0380284
Key People
Amarjit Arun Dhalpe Director Shruti Amarjit Dhalpe Director

Recognitions & Rankings of Vagmine Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-26-0380284

Contact details

Vagmine Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Pno 92 Rajland Colony Tal Maval Dist Pune Talegaon, Maharashtra, India – 410507
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Vagmine Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Vagmine Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Vagmine Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Vagmine Pharmaceuticals Private Limited, buy the company report.

Financials of Vagmine Pharmaceuticals Private Limited

FY 2025 filings available

Vagmine Pharmaceuticals Private Limited reported revenue of ₹3.13 Lakh (down 37% YoY) for FY 2025.

Revenue · FY 2025
₹3.13 Lakh ▼ 37%
Net profit · FY 2025
₹5,704 margin 1.8%
EBITDA · FY 2025
₹7,708 margin 2.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 37%
3 years · compounded
▼ 42%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▼ 63%

Revenue has declined at a compounded annual rate (CAGR) of 42% over three years, including a 37% fall in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹7,708
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5,704
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.5%
Net Profit Margin1.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Vagmine Pharmaceuticals Private Limited, buy the company report.

Board of directors of Vagmine Pharmaceuticals Private Limited

Vagmine Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Amarjit Arun Dhalpe
Also directs: Vagmine Healthcare Private Limited
Director20 Feb 20206 Years 8 MonthsCurrent
Shruti Amarjit Dhalpe
Also directs: Vagmine Healthcare Private Limited
Director20 Feb 20206 Years 8 MonthsCurrent
View all directors

Auditor

Vagmine Pharmaceuticals Private Limited is audited by S A N N & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
S A N N & COFY 2021144916W

Shareholding

The shareholding of Vagmine Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Vagmine Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Vagmine Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Vagmine Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Vagmine Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Amarjit Arun Dhalpe was appointed as Director on 20 Feb 2020.

AGM
Vagmine Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vagmine Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Amarjit Arun Dhalpe was appointed as Director.
Appointed
Shruti Amarjit Dhalpe was appointed as Director.
Incorporation
20 Feb 2020
Vagmine Pharmaceuticals Private Limited was registered on 20 Feb 2020 with Roc Pune & aged 6 years 8 months as per MCA records.

Frequently asked questions

Vagmine Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 February 2020 (6+ years old) and is registered under CIN U33209PN2020PTC189998.

Vagmine Pharmaceuticals has 2 current directors:

The latest financial statements of Vagmine Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The CIN (Corporate Identification Number) of Vagmine Pharmaceuticals is U33209PN2020PTC189998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Vagmine Pharmaceuticals was incorporated on 20 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.

Amarjit Arun Dhalpe was appointed as Director on 20 Feb 2020. Shruti Amarjit Dhalpe was appointed as Director on 20 Feb 2020.

Yes, Vagmine Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0380284).

The registered office of Vagmine Pharmaceuticals is at Pno 92 Rajland Colony Tal Maval Dist Pune Talegaon, Maharashtra, India – 410507.

Vagmine Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

Vagmine Pharmaceuticals can be reached at its registered office: Pno 92 Rajland Colony Tal Maval Dist Pune Talegaon, Maharashtra, India – 410507.